TFS HealthScience (TFS), a global contract research organization (CRO), acquires
Ophthalmology is a rapidly growing field of medicine, with novel innovations and cutting-edge treatments for sight-threatening diseases.
"The acquisition is fully in line with Ratos strategy, where add-on acquisitions as part of growing existing companies in the group are an important part. We are proud of the successful development of TFS and look forward to a new year where TFS will play an important role in our increased commitment to professional services", says
The strategic acquisition of Appletree will complement TFS HealthScience's mission to be a market leader in ophthalmology research. The two companies will now offer complimentary and expanded service offerings to clients, including a specialized therapeutic focus in ophthalmology, significantly expanding the company's global footprint.
"We are proud to partner with Appletree as we continue to provide our clients with in-depth, comprehensive knowledge and therapeutic expertise, particularly in the field of ophthalmology," said CEO of TFS HealthScience,
About TFS HealthScience
TFS HealthScience is a global Contract Research Organization (CRO) that supports biotechnology and pharmaceutical companies throughout their entire clinical development journey. In partnership with customers, they build solution-driven teams working for a healthier future. Bringing together nearly 800 professionals, TFS delivers tailored clinical research services in more than 40 countries.
About
For more information, please contact
About Ratos
Ratos is a business group consisting of 16 companies divided into three business areas: Construction & Services, Consumer and Industry. The companies have approximately
https://news.cision.com/ratos-ab/r/ratos-company-tfs-healthscience-acquires-appletree-ci-group,c3701330
https://mb.cision.com/Main/17707/3701330/1796246.pdf
(c) 2023 Cision. All rights reserved., source